Clinical Trial Detail

NCT ID NCT03840902
Title M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors EMD Serono Research & Development Institute, Inc.
Indications

lung non-small cell carcinoma

Therapies

Carboplatin + Paclitaxel

M7824

Cisplatin + Etoposide

Durvalumab

Cisplatin + Etoposide + M7824

Carboplatin + M7824 + Paclitaxel

Cisplatin + M7824 + Pemetrexed Disodium

Cisplatin + Pemetrexed Disodium

Age Groups: adult senior

Additional content available in CKB BOOST